Biotechnology News XIFAXAN Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-7 out of 7 found

Current Search: xifaxan: 7

Zacks Sell List Highlights: Coventry Health Care, AU Optronics Corp, Saks, Salix Pharmaceuticals
CHICAGO-- (BUSINESS WIRE) -- Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List Stocks to Sell Now.

These stocks are currently rated as a Zacks Rank #5 (Strong Sell): Coventry...

SmartBrief: Jul 19 2008 3:53AM
Matching: xifaxan

Find similar documents

Zacks Sell List Highlights: Coventry Health Care, AU Optronics Corp, Saks, Salix Pharmaceuticals
CHICAGO--(BUSINESS WIRE)--Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List Stocks to Sell Now.

These stocks are currently rated as a Zacks Rank #5 (Strong Sell): Coventry Health...

Yahoo! Canada: Jul 18 2008 7:39PM
Matching: xifaxan

Find similar documents

Salix Initiates Phase 3 For Rifaximin in Non-Constipation Irritable Bowel Syndrome
- Salix Pharmaceuticals, Ltd.

(NASDAQ:SLXP) today announced that the Company has initiated patient enrollment in TARGET 1 and TARGET 2, its Phase 3, randomized, double-blind, placebo-controlled, multicenter studies to assess the efficacy...

Pharma Live: Jul 1 2008 1:45PM
Matching: xifaxan

Find similar documents

/C O R R E C T I O N -- Salix Pharmaceuticals/
In the news release, National Pharmaceutical Company to Sponsor Popular Indianapolis Walk, issued earlier today by Salix Pharmaceuticals over PR Newswire, we are advised by the company that the headline should read 'National Pharmaceutical...

Yahoo! Canada: Jun 12 2008 5:08PM
Matching: xifaxan

Find similar documents

Salix Pharmaceuticals Receives Approvable Letter from FDA for Balsalazide Tablet
Company Website: http:www.salix.comRALEIGH, N.C.

-- (Business Wire) Salix Pharmaceuticals, Ltd.

(NASDAQ:SLXP) today announced that the Company has received an approvable letter from the U.S.

Food and Drug Administration (FDA) for...

Stockwatch: May 17 2008 12:19AM
Matching: xifaxan

Find similar documents

Salix Pharmaceuticals Receives Approvable Letter from FDA for Balsalazide Tablet
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd.

(NASDAQ:SLXP - News) today announced that the Company has received an approvable letter from the U.S.

Food and Drug Administration (FDA) for balsalazide tablet studied as a...

Business Wire via Yahoo!: May 17 2008 12:05AM
Matching: xifaxan

Find similar documents

Salix Pharmaceuticals Announces 1Q2008 Financial Results Conference Call and Web Cast
Company Website: http:www.salix.comRALEIGH, N.C.

-- (Business Wire) Salix Pharmaceuticals, Ltd.

(NASDAQ:SLXP) today announced that the Company will report first quarter ended March 31, 2008 financial results following the close of the U...

Stockwatch: Apr 22 2008 11:08AM
Matching: xifaxan

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.